Breaking Finance News

Thermo Fisher Scientific Inc. (NYSE:TMO) target bumped up to $172.00, released a ratings update earlier today by Zacks Investment Research

Zacks Investment Research bumped up the target of Thermo Fisher Scientific Inc. (NYSE:TMO) to $172.00 indicating a possible upside of 0.12%.

Yesterday Thermo Fisher Scientific Inc. (NYSE:TMO) traded -0.21% lower at $153.80. TMO’s 50-day average is $153.51 and its two hundred day average is $151.02. With the last close up 0.46% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Trade Volume was up over the average, with 1,477,936 shares of TMO changing hands over the typical 1,372,560

Recent Performance Chart

Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Inc. has price-earnings ratio of 30.35 with a one year low of $119.75 and a one year high of $160.68 and has a total market value of $0.

A total of 18 brokers have issued a report on the stock. 11 brokers rating the stock a strong buy, 9 brokers rating the stock a buy, 1 firm rating the stock a hold, 1 firm rating the stock a underperform, and finally 0 firms rating the stock a sell with a consensus target price of $162.25.

About Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *